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a b s t r a c t
Using zebraﬁsh as amodel, we previously reported that developmental exposure to triphenyl phosphate
(TPP) – a high-production volume organophosphate-based ﬂame retardant – results in dioxin-like car-
diac looping impairments that are independent of the aryl hydrocarbon receptor. Using a pharmacologic
approach, theobjectiveof this studywas to investigate thepotential role of retinoic acid receptor (RAR)–a
nuclear receptor that regulates vertebrateheartmorphogenesis – inmediatingTPP-induceddevelopmen-
tal toxicity in zebraﬁsh. We ﬁrst revealed that static exposure of zebraﬁsh from 5–72h post-fertilization
(hpf) to TPP in the presence of non-toxic concentrations of an RAR antagonist (BMS493) signiﬁcantly
enhanced TPP-induced toxicity (relative to TPP alone), even though identical non-toxic BMS493 concen-
trations mitigated retinoic acid (RA)-induced toxicity. BMS493-mediated enhancement of TPP toxicity
was not a result of differential TPPuptake ormetabolism, as internal embryonic doses of TPP anddiphenyl
phosphate (DPP) – a primary TPP metabolite – were not different in the presence or absence of BMS493.
Using real-time PCR, we then quantiﬁed the relative change in expression of cytochrome P450 26a1
(cyp26a1) – a major target gene for RA-induced RAR activation in zebraﬁsh – and found that RA and
TPP exposure resulted in a ∼5-fold increase and decrease in cyp26a1 expression, respectively, relative
to vehicle-exposed embryos. To address whether TPP may interact with human RARs, we then exposed
Chinese hamster ovary cells stably transfected with chimeric human RAR-, RAR-, or RAR to TPP
in the presence of RA, and found that TPP signiﬁcantly inhibited RA-induced luciferase activity in a
concentration-dependent manner. Overall, our ﬁndings suggest that zebraﬁsh RARs may be involved
in mediating TPP-induced developmental toxicity, a mechanism of action that may have relevance to
humans.
© 2015 Elsevier B.V. All rights reserved.
1. Introduction
Triphenyl phosphate (TPP) is an unsubstituted aryl phosphate
ester historically used as ahigh-production volumeﬂame retardant
within polyvinyl chloride, polymers, printed circuit boards, photo-
graphic ﬁlms, and hydraulic ﬂuids (Brooke et al., 2009). Based on
estimates from10 to15years ago, the combinedproduction anduse
of TPP within Western Europe was 20,000–30,000 tons (or 44–66
Abbreviations: AHR, aryl hydrocarbon receptor; BMS4934, -[(1E)-2-[5,6-
dihydro-5,5-dimethyl8-(2-phenylethynyl)-2-naphthalenyl]ethenyl]benzoic acid;
cyp26a1, cytochrome P450 26a1; DMSO, dimethyl sulfoxide; DPP, diphenyl
phosphate; hpf, hours post-fertilization; MS-222, tricaine methanesulfonate; RA,
retinoic acid; RAR, retinoic acid receptor; TPP, triphenyl phosphate.
∗ Corresponding author. Tel.: +1 803 777 0218; fax: +1 803 777 3391.
E-mail address: volz@mailbox.sc.edu (D.C. Volz).
million pounds) in 2000, while the combined production and use
of TPP within the United States alone was 4500–22,700 tons (or
10–50 million pounds) (van der Veen and de Boer, 2012). Since
2005, the use of TPP as a ﬂame retardantwithin polyurethane foam
likely increasedwithin theUnited States following the phase-out of
pentabrominateddiphenyl etherandsubsequent replacementwith
alternative TPP-containing ﬂame retardant formulations (USEPA,
2005). Similar to pentabrominated diphenyl ether, TPP is an addi-
tive ﬂame retardant that can migrate from end-use products into
indoor and outdoor environmental media (van der Veen and de
Boer, 2012). As such, environmental exposure to TPP may pose a
health risk to humans and ecological species, particularly during
sensitive windows of development.
Using zebraﬁsh embryos, we recently evaluated the potential
developmental toxicity of brominated and aryl phosphate com-
ponents (including TPP) present within Firemaster 550 (McGee
http://dx.doi.org/10.1016/j.aquatox.2015.02.009
0166-445X/© 2015 Elsevier B.V. All rights reserved.
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et al., 2013), an increasingly used alternative formulation for
polyurethane foam. Within this study, exposure to TPP and
mono-isopropylated triaryl phosphate – but not the remaining
brominated and aryl phosphate components of Firemaster 550 –
blocked normal looping of the atrium and ventricle, resulting in a
“tube heart” phenotype. In addition, heart malformations result-
ing frommono-isopropylated triaryl phosphate exposure – but not
TPP exposure– were blocked in the presence of an aryl hydro-
carbon receptor (AHR) antagonist (1-methyl-N-[2-methyl-4-[2-(2-
methylphenyl) diazenyl]phenyl-1H-pyrazole-5-carboxamide, or
CH223191). Therefore, since TPP-induced malformations appear
to be AHR-independent, it is currently unclear how TPP induces
developmental toxicity in zebraﬁsh and whether this mechanism
of action is conserved within other vertebrates.
Although TPP is known to activate human pregnane X recep-
tor (Honkakoski et al., 2004; Kojima et al., 2013) and peroxisome
proliferator-activated receptor  (Belcher et al., 2014; Pillai et al.,
2014), these tworeceptorsarenotknowntoplayamajor role in reg-
ulating cardiac development within vertebrates. However, retinoic
acid receptor (RAR) is a ligand-activated nuclear receptor that; (1)
directly controls heart morphogenesis in zebraﬁsh (Stainier and
Fishman, 1992) and mice (Niederreither et al., 2001); (2) when
over-activated by excess retinoic acid (RA), blocks normal cardiac
looping within zebraﬁsh (Chen et al., 2008); and (3) is activated
by structurally diverse xenobiotics (Kamata et al., 2008). While
mammals have three RAR orthologs (RAR-, RAR-, and RAR)
(Bastien and Rochette-Egly, 2004), zebraﬁsh lack RAR and pos-
sess two different paralogs of RAR (raraa and rarab) and RAR
(rarga and rargb) (Waxman and Yelon, 2007). Despite these differ-
ences, cytochrome P450 26a1 (cyp26a1) is a major target gene for
RA-induced RAR activation in zebraﬁsh (White et al., 1996), mice
(Ray et al., 1997), and humans (White et al., 1997), representing a
biomarker for assessing potential RAR activation in vivo.
Based on our previous ﬁndings relative to data available within
the literature, the overall objective of this study was to begin
investigating the potential role of RAR in mediating TPP-induced
developmental toxicity in zebraﬁsh. To accomplish this objec-
tive, we relied on a combination of high-content screening assays,
real-time PCR, and human RAR reporter assays to test the hypoth-
esis that TPP-mediated RAR activation results in developmental
toxicity, a mechanism that, similar to our ﬁndings with mono-
isopropylated triaryl phosphate (McGee et al., 2013), may have
relevance to humans. We also quantiﬁed internal embryonic doses
of TPP and diphenyl phosphate (DPP) – a primary TPP metabolite
– to conﬁrm uptake of TPP and determine whether TPP and DPP
doses were affected by the presence of an RAR antagonist.
2. Materials and methods
2.1. Animals
For all assays described below, we relied on a robust line of
transgenic zebraﬁsh (ﬂi1:egfp) that stably express enhanced green
ﬂuorescent protein within vascular endothelial cells (Lawson and
Weinstein, 2002). Althoughwe did not assess the potential impacts
of chemical exposure on angiogenesis within this study, we relied
on ﬂuorescent ﬂi1:egfp zebraﬁsh to analyze heart rate and body
length using previously optimized protocols (Yozzo et al., 2013).
Adult ﬂi1:egfp zebraﬁshweremaintained on a 14-h:10-h light:dark
cyclewithin a ﬁve-shelf stand-alone system (Aquatic Habitats, Inc.,
Apopka, FL,USA) containingphotoperiod light-cycleenclosuresand
recirculating conditioned reverse osmosiswater. Dissolvedoxygen,
pH, conductivity, salinity, alkalinity, and temperature within recir-
culating water were maintained at 4-6mg/L, 6.5–7.5, 425–475S,
<1ppt, 50–100mg/L, and 27–28 ◦C, respectively; in addition, levels
of ammonia, nitrite, and nitrate within recirculating water were
consistently below 0.1mg/L, 0.05mg/L, and 2mg/L, respectively.
Adult females and males were bred directly on-system using in-
tank breeding traps suspendedwithin 3-L tanks, or bred off-system
within a light- and temperature-controlled incubator using breed-
ing traps suspendedwithin 1-L tanks. For all experiments described
below, newly fertilized eggs were staged according to previously
described methods (Kimmel et al., 1995). All ﬁsh were handled
and treated in accordance with approved Institutional Animal Care
and Use Committee protocols at the University of South Carolina –
Columbia.
2.2. Chemicals
TPP (99.5% purity) was purchased from ChemService, Inc.
(West Chester, PA, USA), whereas all-trans-RA (99.7% purity)
and 4-[(1E)-2-[5,6-dihydro-5,5-dimethyl-8-(2-phenylethynyl)-2-
naphthalenyl]ethenyl]benzoic acid (BMS493, 98.2% purity) were
purchased from R&D Systems (Minneapolis, MN, USA). Stock solu-
tions of each chemical were prepared by dissolving chemicals in
high performance liquid chromatography-grade dimethyl sulfox-
ide (DMSO) (50mM), and then performing two-fold serial dilutions
into DMSO to create stock solutions for each working solution.
All stock solutions were stored at room temperature within 2-mL
amber glass vials containing polytetraﬂuoroethylene-lined caps.
Working solutions of tricaine methanesulfonate (MS-222) (West-
ern Chemical, Inc., Ferndale, WA, USA) were freshly prepared by
dissolving MS-222 into embryo media (5mM NaCl, 0.17mM KCl,
0.33mM CaCl2, 0.33mM MgSO4), and working solutions of all
treatments were freshly prepared by spiking stock solutions into
embryo media, resulting in 0.1% DMSO within all vehicle control
and treatment groups.
2.3. High-content screening assays with RA, TPP, and BMS493
2.3.1. Exposure setup
Black 384-well microplates containing 0.17-mm glass-bottom
wells (Matrical Bioscience, Spokane, WA, USA) were used for
all high-content screening assays. Immediately following spawn-
ing, newly fertilized eggs were collected and placed in groups
of approximately 50 per plastic petri dish within a light- and
temperature-controlled incubator until 5 h post-fertilization (hpf).
For each assay, 384 viable ﬂi1:egfp embryos were arrayed at 5
hpf into a 384-well plate (one embryo per well; 32 embryos
per treatment) containing 50L per well of vehicle (0.1% DMSO)
or treatment solution (0.1–100nM RA; 0.05–50M TPP; or
0.05–50MBMS493), and then incubatedat 28 ◦Cunder a14-h:10-
h light:dark cycle and static conditions until 72hpf.
2.3.2. Image acquisition
At 72hpf, the plate was removed from the incubator, and
zebraﬁsh embryos were anesthetized with 100mg/L MS-222 by
adding 25L of 300mg/L MS-222 to 50L of vehicle or treatment
solution. The plate was then centrifuged at 200 rpm for 2min to
help orient hatched embryos into right or left lateral recumbency.
Using automated image acquisition protocols and parameters pre-
viously optimized (Yozzo et al., 2013) for our ImageXpress Micro
Wideﬁeld High-Content Screening System (Molecular Devices,
Sunnyvale, CA, USA), each embryo was imaged to analyze the fol-
lowing endpoints: heart rate, pericardial area, and body length.
During the entire image acquisition period, internal temperature
within the ImageXpress Micro system was maintained between
25 and 27 ◦C by removing panels on both sides of the ImageX-
press Micro system and blowing air from left to right through
the ImageXpress Micro with a portable fan; internal temperature
was monitored and recorded at initiation and termination of each
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imaging protocol using a digital thermometer. Following comple-
tion of image acquisition, 72-hpf embryoswere then euthanized by
placing the plate at 4 ◦C for 30min.
2.3.3. Data extraction
Within MetaXpress 4.0.0.24 software (Molecular Devices, Sun-
nyvale, CA, USA), custom journal scripts for extraction of heart
rate, pericardial area, and body length data were used as previ-
ously described (Yozzo et al., 2013). Prior to data extraction, stream
acquisitions within each well were inspected within MetaXpress
to assess embryo orientation and survival. Coagulated embryos,
unhatched embryos, grossly malformed embryos, or developed
embryos lacking a heartbeat were not included in the analysis.
Using these criteria, only hatched and live embryos positioned in
right or left lateral recumbency were analyzed. Interactive semi-
automated journal scripts were used to isolate regions of interest
and quantify heart rate and pericardial area, whereas a fully auto-
mated journal script was used to quantify body length. Examples
of raw and analyzed images for each endpoint as well as addi-
tional details of the data extraction and analysis process have been
previously described (Yozzo et al., 2013).
2.4. BMS493 co-exposures
Weused a pan-RAR antagonist (BMS493) to determinewhether
TPP-induced developmental toxicity was RAR-dependent. Based
on exposures described in Section 2.3 and using pericardial area
as an endpoint, non-toxic BMS493 concentrations selected for
co-exposure experiments were 0.19 and 0.39M. Using identical
exposure set-up and image acquisition protocols described in Sec-
tion 2.3, we exposed embryos to RA (25, 50, or 100nM) or TPP
(3.125, 6.25, or 12.5M) in the presence or absence of 0.19 or
0.39MBMS493. For TPP-BMS493 co-exposures, we extracted and
analyzed data for pericardial area, as this endpoint represented
a readily measurable biomarker for cardiac looping defects. For
RA-BMS493 co-exposures, we manually quantiﬁed the distance
from the caudal ﬁn to the anteroposterior axis within MetaXpress
(Fig. S1) since RA disrupted normal caudal ﬁn development in the
absence of detectable effects on heart rate and pericardial area.
2.5. Quantiﬁcation of internal embryonic doses of TPP and DPP
To quantify internal embryonic doses of TPP and DPP, 5-hpf
ﬂi1:egfp embryos (20 embryos per well; six wells per treatment)
were arrayed into a clear 48-well Falcon tissue culture plate (Corn-
ing Life Sciences, Tewksbury, MA, USA) containing 1mL per well
of vehicle (0.1% DMSO) or 12.5M TPP in the presence or absence
of 0.39M BMS493. Embryos were incubated at 28 ◦C under a 14-
h:10-h light:dark cycle and static conditions until 72hpf, and then
euthanized with an overdose of MS-222. For each replicate pool
(three per treatment), 30 72-hpf embryoswere combined from two
replicate wells into a 2-mL cryovial, immediately snap-frozen in
liquid nitrogen, and stored at −80 ◦C until analysis.
Immediately prior to extraction, samples were spiked with
deuterated TPP (d15-TPP) and deuterated DPP (d10-DPP). Ana-
lytes were extracted and quantiﬁed using previously published
methods (Dishaw et al., 2014; McGee et al., 2012). Brieﬂy, tissue
homogenates were sonicated three times in 1mL acetonitrile for
20min. Combined acetonitrile extracts were concentrated to dry-
ness under N2 at 35 ◦C and reconstituted in 1:1 methanol:water.
Prior to analysis, particulates were removed using a 0.2-M
nylon membrane. Tissue extracts were analyzed using liquid
chromatography-tandem mass spectrometry (LC/MS–MS) on an
Agilent 1200 series LC connected to an Agilent 6410B triple
quadrupole MS detector equipped with an electrospray ioniza-
tion source. Analytes were separated chromatographically on a
Kinetex XB-C18 column (100mm×2.1mm, 2.6m; Phenomenex)
using a methanol–water gradient. Analytes were detected using
multiple reactionmonitoring inpositive (TPPandd15-TPP) andneg-
ative (DPP and d10-DPP) ionizationmodes.Method detection limits
(MDLs) were deﬁned as three times the standard deviation of lab
blanks (if present) or three times the noise. MDLs for TPP and DPP
were 1.7 and 0.15ng, respectively.
2.6. Total RNA isolation and real-time PCR
To assess the potential effects of RA and TPP on cyp26a1 expres-
sion, 5-hpf ﬂi1:egfp embryos (20 embryos per well; 12 wells per
treatment) were arrayed into a clear 48-well Falcon tissue cul-
ture plate (Corning Life Sciences, Tewksbury, MA, USA) containing
1mL per well of vehicle (0.1% DMSO), 100nM RA, or 12.5M TPP.
Embryoswere incubatedat28 ◦Cundera14-h:10-h light:dark cycle
and static conditions until 72hpf, and then euthanized with an
overdose of MS-222, immediately snap-frozen in liquid nitrogen,
and stored at −80 ◦C until RNA extraction procedures.
After combining three replicate wells per pool, four replicate
pools of 60 72-hpf embryos per pool were homogenized in 2-mL
cryovialsusingaPowerGenHomogenizer (ThermoFisherScientiﬁc,
Waltham, MA, USA). Following homogenization, a SV Total RNA
Isolation System (Promega, Madison, WI, USA) was used to extract
total RNA from each replicate sample per manufacturer’s instruc-
tions. First-strand cDNAs were generated from total RNA using
oligo(dT)15 primers and AMV Reverse Transcriptase (Promega,
Madison, WI, USA) and stored at −20 ◦C until use. cyp26a1 and
18 s rRNA cDNAs were ampliﬁed using the following primers:
cyp26a1, forward primer 5′-GATGCTCTGGAGCACTACATTC-3′,
reverse primer 5′-GTTCTTGCTCGTCCGTCTTTAT-3′; and 18 s rRNA,
forward primer, 5′-TCGCTAGTTGGCATCGTTTATG-3′, reverse
primer 5′-CGGAGGTTCGAAGACGATCA-3′. 18 s rRNA was selected
as an internal control because it is stably expressed through-
out zebraﬁsh embryogenesis (McCurley and Callard, 2008). Per
manufacturer’s instructions, approximately 150ng of cyp26a1
and 18 s rRNA cDNA was PCR ampliﬁed in duplicate using GoTaq
qPCR Master Mix (Promega, Madison, WI, USA) and an Applied
Biosystems 7900HT Fast Real-Time PCR System (Life Technologies,
Grand Island, NY, USA). Real-time PCR reaction conditions were
2min at 95 ◦C followed by 45 cycles of 95 ◦C for 30 s, 51 ◦C for
30 s, and 72 ◦C for 30 s. Relative quantitation of gene expression
within each treatment was calculated using the comparative cycle
threshold method as previously described (Jayasinghe and Volz,
2012).
2.7. Human RAR reporter assays
A cell-based human RAR-driven luciferase reporter assay
developed and conducted by the Services Group within
INDIGO Biosciences (State College, PA) was used to deter-
mine whether TPP antagonized RA-induced activation of
human RAR-, RAR-, or RAR. 9-cis RA was used as an
agonist for RAR, whereas all-trans RA was used as an
agonist for RAR and RAR. 4-[[[5,6-Dihydro-5,5-dimethyl-
8-(3-quinolinyl)-2-naphthalenyl]carbonyl]amino]benzoic acid
(BMS195614) was used as a reference antagonist for RAR, and
4-[6-[(2-methoxyethoxy) methoxy]-7-tricyclo[3.3.1.13,7]dec-1-
yl-2-naphthalenyl) benzoic acid (CD2665) was used as a reference
antagonist for RAR and RAR. Concentrated TPP stockwas serially
diluted in DMSO to yield 3.1, 6.3, 13, 25, 50, and 100mM working
stocks, and concentrated reference antagonist stocks were serially
diluted in DMSO to yield 0.0006, 0.002, 0.01, 0.04, 0.16, 0.63, 2.5,
and 10mM working stocks. Treatment solutions were prepared
by diluting working stocks in INDIGO’s proprietary culture media,
resulting in 0.1% DMSO within all wells. For positive control
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wells, 9-cis or all-trans RA was added at a ﬁnal concentration
that increased luminescence by ∼80% relative to negative control
wells. Treatment wells contained identical 9-cis or all-trans RA
concentrations as positive control wells, but also contained TPP
(3.1, 6.3, 13, 25, 50, or 100M), BMS195614 (0.0006, 0.002, 0.01,
0.04, 0.16, 0.63, 2.5, or 10M), or CD2665 (0.0006, 0.002, 0.01,
0.04, 0.16, 0.63, 2.5, or 10M).
For each treatment group, spiked culture media (100L) was
dispensed into triplicate assay wells (using a white 96-well
microplate) containing Chinese hamster ovary cells stably trans-
fected with (1) expression vector containing the N-terminal GAL4
DNA binding domain fused to the ligand binding domain of human
RAR-, RAR-, or RAR and (2) reporter vector containing a ﬁreﬂy
luciferase gene functionally linked to the GAL4-speciﬁc upstream
activation sequence. Following a 24-h incubation at 37 ◦C under
5% carbon dioxide (CO2), treatment media was discarded and, fol-
lowing one rinse with INDIGO’s proprietary live cell multiplex
buffer, live cell multiplex substrate was added to each well of
the assay plate to assess cell viability. Following incubation at
37 ◦C for 30min, ﬂuorescence was quantiﬁed to determine the
relative number of live cells per well, and then live cell multi-
plex substrate was discarded and 100L of ONE-Glo Luciferase
Assay Reagent (Promega, Madison, WI, USA) was added to each
well of the assay plate. After a 5-min incubation at room temper-
ature, luminescence was quantiﬁed using a Glomax 96 microplate
luminometer (Promega,Madison,WI, USA).Meanﬂuorescence and
luminescence (±standard deviation) values were calculated for
each treatment group based on triplicate wells per treatment. For
cell viability data, mean ﬂuorescence for each treatment groupwas
normalized to mean ﬂuorescence for RA-only wells to determine
the percent change in cell viability relative to positive controlwells.
2.8. Statistical analyses
All statistical procedures were performed using SPSS Statistics
21. A general linear model (GLM) analysis of variance (ANOVA)
(˛=0.05) was used for all data derived from high-content screen-
ing assays, real-time PCR, analytical chemistry, and human RAR
reporter assays, as these data did not meet the equal variance
assumption for non-GLM ANOVAs. Pair-wise Tukey-based multi-
ple comparisons of least square means were performed to identify
signiﬁcant treatment-related effects relative to vehicle controls,
as well as BMS493-related effects relative to corresponding treat-
ments without BMS493.
3. Results
3.1. RA, TPP, and BMS493 are toxic to developing zebraﬁsh
embryos
RA resulted in 56–72% survival following exposure to
0.78–50nM, whereas exposure at the highest concentration
Fig. 1. Developmental toxicity of RA to 72-hpf zebraﬁsh following static exposure from 5–72hpf. (A) Embryo survival; (B) mean body length (±standard deviation); (C)mean
heart rate (±standard deviation); and (D) mean pericardial area (±standard deviation). Asterisk (*) denotes signiﬁcant treatment effect (p<0.05) relative to vehicle controls
(0.1% DMSO). N=32 initial embryos per control or treatment group.
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Fig. 2. Developmental toxicity of TPP to 72-hpf zebraﬁsh following static exposure from 5–72hpf. (A) Embryo survival; (B) mean body length (±standard deviation); (C)
mean heart rate (±standard deviation); and (D) mean pericardial area (±standard deviation). Asterisk (*) denotes signiﬁcant treatment effect (p<0.05) relative to vehicle
controls (0.1% DMSO). N=32 initial embryos per control or treatment group.
(100nM) resulted in <50% survival (Fig. 1A). Body length (Fig. 1B)
and pericardial area (Fig. 1D) were also signiﬁcantly decreased and
increased, respectively, at 100nM. However, RA exposure resulted
in no effect on heart rate at all concentrations tested (Fig. 1C), and
no effect on body length and pericardial area at concentrations
≤50nM. A representative image of a 72-hpf embryo treated with
50nM RA is provided in Fig. S2.
TPP resulted in <50% survival at thehighest concentration tested
(50M) (Fig. 2A), while body length was signiﬁcantly decreased
at 25 and 50M (Fig. 2B). Pericardial area was signiﬁcantly
increased in a concentration-dependent manner at concentrations
>3.125M (Fig. 2D). However, similar to RA, TPP exposure resulted
in no signiﬁcant effects on heart rate at all concentrations tested
(Fig. 2C). A representative image of a 72-hpf embryo treated with
12.5M TPP is provided in Fig. S2.
BMS493 was signiﬁcantly more toxic than TPP, resulting in a
steep concentration-dependent effect on survival and 100% mor-
tality following exposure to >1.56M (Fig. 3A). While body length
was not affected following exposure to≤1.56M(Fig. 3B), BMS493
exposure resulted ina signiﬁcant increase inpericardial area at con-
centrations ≥0.78M (Fig. 3D). Moreover, while pericardial area
was not affected at 0.39M and lower, BMS493 exposure signif-
icantly decreased heart rate by 25–50 beats per minute (bpm)
relative to vehicle controls at all concentrations except 0.05 and
0.78M (Fig. 3C). A representative image of a 72-hpf embryo
treated with 1.56M BMS493 is provided in Fig. S2.
3.2. BMS493 enhances TPP-induced toxicity in zebraﬁsh embryos
Whileexposure to50and100nMRAalone resulted inadecrease
in percent survival and increase in distance from the caudal ﬁn to
the anteroposterior axis (Fig. 4A andB), non-toxic concentrations of
BMS493 (0.19 and 0.39M)mitigated RA-inducedmortality (≥75%
survival across all co-exposures) and caudal ﬁn malformations
in a concentration-dependent manner (Fig. 4B). However, unlike
RA, co-exposure of embryos to 3.125–12.5M TPP and non-toxic
concentrations of BMS493 resulted in a signiﬁcant increase in peri-
cardial area (Fig. 4C andD) – an effect thatwas further enhanced by
increasing BMS493 concentrations. Representative images of 72-
hpf embryos treatedwith100nMRAor12.5MTPP in thepresence
or absence of 0.39M BMS493 are provided in Fig. S3.
3.3. Co-exposure with BMS493 does not affect internal embryonic
doses of TPP or DPP
Mean internal embryonic doses of TPP following a static 5–72-
hpf exposure to vehicle (0.1% DMSO), 12.5M TPP, 0.39M
BMS493, or 12.5M TPP+0.39M BMS493 were 1.46, 443.44,
2.41, and 453.83ng/30 embryos, respectively (Fig. 5). Mean inter-
nal embryonic doses of DPP within these same treatments were
<MDL, 1.75, <MDL, and 0.93, respectively (Fig. 5). Although TPP
doses were signiﬁcantly higher in both TPP treatments relative to
vehicle controls, there were no signiﬁcant differences in TPP and
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Fig. 3. Developmental toxicity of BMS493 to 72-hpf zebraﬁsh following static exposure from 5–72hpf. (A) Embryo survival; (B) mean body length (±standard deviation);
(C) mean heart rate (±standard deviation); and (D) mean pericardial area (±standard deviation). Asterisk (*) denotes signiﬁcant treatment effect (p<0.05) relative to vehicle
controls (0.1% DMSO). N=32 initial embryos per control or treatment group.
DPP doses within the TPP-BMS493 co-exposure compared to TPP
alone (Fig. 5). Therefore, the presence of non-toxic BMS493 concen-
trations within the exposure media did not affect internal doses of
TPP and DPP within 72-hpf embryos.
3.4. TPP exposure decreases cyp26a1 expression in zebraﬁsh
embryos
As described in Section 3.2, co-exposure to BMS493 did notmit-
igate – but rather enhanced – TPP-induced developmental toxicity
in zebraﬁsh. As a result, we quantiﬁed the potential effect of RA
and TPP on cyp26a1 expression in order to (1) conﬁrm that RA
exposure resulted in an increase in cyp26a1 expression and (2) test
the hypothesis that TPP exposure decreased cyp26a1 expression.
Indeed,while RA exposure resulted in a∼5-fold increase in cyp26a1
expression (Fig. 6), TPP exposure resulted in a ∼5-fold decrease in
cyp26a1 expression (Fig. 6).
3.5. TPP inhibits RA-induced activation of human RAR˛-, RARˇ-,
and RAR
Using Chinese hamster ovary cells stably transfected with
chimeric human RAR-, RAR-, or RAR, TPP signiﬁcantly inhib-
ited RA-induced luciferase activity at 50 and 100M for human
RAR and RAR and 100M for human RAR (Fig. 7). Cell viability
(percent live cells) was ≥86% across all three assays for reference
antagonist exposures and all TPP concentrations except for the
highest concentration (100M);within this TPP concentration, cell
viability was ≥74% across all three assays (Table S1).
4. Discussion
Within this study, we found that TPP exposure was toxic to
developing zebraﬁsh embryos, albeit at high nominal aqueous con-
centrations. Although the toxicity of TPP within adult animals
(including zebraﬁsh) has been extensively evaluated (Brooke et al.,
2009; Liu et al., 2012, 2013; USEPA, 2005), to our knowledge the
potential toxicity of TPP during early vertebrate development has
received little attention. To date, only one prenatal developmen-
tal toxicity study and one ﬁsh early life-stage study using rats
and fathead minnows, respectively, have reported adverse ﬁnd-
ings (Brooke et al., 2009; USEPA, 2005). Within Sprague–Dawley
rats, daily exposure to 690mg/kg/day TPP (the highest dose tested)
decreased dam body weight in the absence of teratogenic effects,
suggesting that maternal metabolism mitigated in utero expo-
sure via transformation of TPP into non-toxic metabolites. Within
fatheadminnows, TPP signiﬁcantly decreased post-hatch (fry) sur-
vival at 230g/L (the highest concentration tested) in the absence
of effects on embryo hatchability, body length, and eye devel-
opment, suggesting that the highest TPP concentration tested
was unable to penetrate the embryonic chorion during devel-
opment. While our ﬁndings demonstrate that TPP is toxic to
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Fig. 4. BMS493 mitigates and enhances RA- and TPP-induced developmental tox-
icity, respectively, in zebraﬁsh. (A) Mean distance (±standard deviation) from
the caudal ﬁn to the anteroposterior axis. (B) Mean pericardial area (±standard
deviation). Asterisk (*) denotes signiﬁcant treatment effect (p<0.05) relative to
within-group vehicle controls (0.1% DMSO), whereas single cross (†) denotes sig-
niﬁcant effect (p<0.05) of BMS493 co-exposure relative to the same concentration
of RA or TPPwithout BMS493.N=32 initial embryos per control or treatment group.
developing zebraﬁsh embryos at higher concentrations (e.g.,
12.5M TPP=4,078g/L TPP), the acute or chronic risk of TPP to
ﬁsh embryos and larvae within aquatic environments is likely neg-
ligible since short- and long-term surfacewater TPP concentrations
are expected to be <10g/L (Brooke et al., 2009; USEPA, 2005).
While administration of exogenous RAwas highly toxic at nom-
inal concentrations >50nM, BMS493was signiﬁcantlymore potent
than TPP and required an approximately 30-fold lower nominal
concentration to induce a similar magnitude of toxicity. Broadly
classiﬁed as an RAR antagonist, BMS493 is a pan-RAR inverse ago-
nist that, upon interaction with the RAR ligand-binding domain,
represses RAR function and decreases expression of RAR target
genes relative to basal transcriptional levels (Germain et al., 2009;
le Maire et al., 2010). While we did not assess the speciﬁcity
of BMS493 to zebraﬁsh RARs, previous studies published nearly
15 years ago conﬁrmed that BMS493 is a potent inhibitor of
RA signaling in vivo within mouse, chick, and zebraﬁsh embryos
(Dupe and Lumsden, 2001; Grandel et al., 2002; Stafford and
Fig. 5. BMS493 does not affect TPP uptake or metabolism to DPP. Mean (±standard
deviation) dose (ng) of TPP or DPP detected in homogenates of 30 whole embryos
exposed to vehicle (0.1% DMSO) or 12.5M TPP in the presence or absence of
0.39M BMS493. Asterisk (*) denotes signiﬁcant treatment effect (p<0.05) rela-
tive to vehicle controls (0.1% DMSO). No signiﬁcant differences in TPP or DPP were
detected within the TPP-BMS493 co-exposure compared to TPP alone. N= three
replicate pools per treatment. MDL=method detection limit.
Prince, 2002; Wendling et al., 2000, 2001). Therefore, in our study,
BMS493-induced toxicity at higher concentrations was likely due
to abolishment of endogenous RA signaling required for normal
embryonic development and survival.
Based on our previously published ﬁndings (McGee et al., 2013),
we hypothesized that aberrant activation of RAR may mediate
TPP-induced developmental toxicity. Contrary to our hypothe-
sis, co-exposure of developing embryos to TPP and non-toxic
BMS493 concentrations signiﬁcantly enhanced toxicity relative
to TPP alone, even though BMS493 mitigated RA-induced mal-
formations. In addition, while RA exposure increased cyp26a1
expression by ∼5-fold, TPP exposure decreased cyp26a1 expres-
sion by ∼5-fold, suggesting that TPP may have repressed RAR
function – either directly or indirectly – relative to basal levels
within vehicle-exposed embryos. Similar to the effect of TPP on
cyp26a1 expression, our previous ﬁndings showed that exposure
of zebraﬁsh embryos to 4M TPP within glass beakers decreased
cyp1a (a major AHR target gene) expression by ∼7-fold (McGee
et al., 2013), suggesting that TPP may affect crosstalk between
the AHR and RAR during embryogenesis. Indeed, available data
Fig. 6. RA and TPP exposure from 5 to 72hpf results in increased and decreased
cyp26a1 expression, respectively, at 72 hpf. Mean fold change data (±standard
deviation) are relative to cyp26a1 expression within vehicle controls. Asterisk (*)
denotes signiﬁcant treatment effect (p<0.05) relative to vehicle controls. N= four
RNA samples derived from four replicate pools of 60 72-hpf embryos per pool.
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Fig. 7. TPP inhibits RA-induced activation of human RAR-, RAR-, and RAR. (A)Mean luminescence (±standard deviation) from human RAR-expressing and RA-activated
Chinese hamster ovary cells following exposure to TPP or BMS195614 (reference RAR antagonist). (B) Mean luminescence (±standard deviation) from human RAR-
expressing and RA-activated Chinese hamster ovary cells following exposure to TPP or CD2665 (reference RAR antagonist). (C) Mean luminescence (±standard deviation)
fromhumanRAR-expressing andRA-activated Chinese hamster ovary cells following exposure to TPP or CD2665 (reference RAR antagonist). Asterisk (*) denotes signiﬁcant
treatment effect (p<0.05) relative to vehicle controls (0.1% DMSO). N= three assay wells per control or treatment group.
within thepublished literature supports thishypothesis, as endoge-
nous RA and normal RAR function are required for expression of
AHR mRNA and proper embryonic development in mice and ﬁsh
(Hayashida et al., 2004; Jacobs et al., 2011).
Within hepatocytes, TPP undergoes rapid enzyme-mediated
hydrolysis and hydroxylation to form DPP and hydroxyl TPP
metabolites, respectively (Sasaki et al., 1984; Su et al., 2014;
Van den Eede et al., 2013). Urinary TPP and DPP concentrations
were recently measured within several adult human populations
(Hoffman et al., 2014a,b,b; Meeker et al., 2013), and results from
these studies suggest that DPP may be a reliable indicator of
human TPP exposure within indoor environments. Therefore, for
this study, we relied on DPP as an indicator of potential TPP
metabolism within developing zebraﬁsh embryos. To determine
whether BMS493 interfered with TPP uptake and/or metabolism,
we quantiﬁed internal embryonic doses of TPP and DPP in 72-hpf
embryos following a 5-72-hpf static exposure to vehicle or TPP in
thepresenceor absenceofBMS493. Interestingly, co-exposurewith
non-toxic concentrations of BMS493 did not affect internal doses of
TPPorDPP, suggesting that (1) TPP is notmetabolized toDPPduring
the ﬁrst 72h of zebraﬁsh embryogenesis and (2) enhanced toxicity
in the presence of BMS493was not due to higher TPP doses relative
to TPP-alone exposures. Rather, these data support the conclusion
that TPP and BMS493 act synergistically within zebraﬁsh embryos,
possibly via direct or indirect interactions with RAR-relevant path-
ways.
Finally, based on our ﬁndings in zebraﬁsh, we hypothesized
that TPP may antagonize RA-induced activation of human RAR-,
RAR-, or RAR. Using Chinese hamster ovary cells stably trans-
fected with chimeric human RAR and luciferase reporter vectors,
TPP signiﬁcantly inhibited RA-induced luciferase activity in a
concentration-dependentmanner. Therefore, our data suggest that
TPP has the potential to interact – albeit very weakly – with the
ligand-binding domain of human RAR-, RAR-, or RAR. TPP is
an agonist for human estrogen receptor , estrogen receptor ,
pregnane X receptor, and peroxisome proliferator-activated recep-
tor  (Belcher et al., 2014; Honkakoski et al., 2004; Kojima et al.,
2013; Pillai et al., 2014) as well as an antagonist for human andro-
gen receptor and glucocorticoid receptor (Kojima et al., 2013). To
our knowledge, this is the ﬁrst study to identify TPP as a poten-
tial human RAR antagonist, supporting the emerging hypothesis
that TPP – an industrial chemical that, unlike drugs and pesticides,
was not designed to exhibit speciﬁcity and target a single class of
receptors–may interact with multiple nuclear receptors localized
within a diverse set of target tissues and organs.
In summary, our data collectively suggest that zebraﬁsh RARs
may be involved in mediating TPP-induced developmental toxic-
ity, a mechanism of action that may have relevance to humans.
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However, we recognize that additional research is needed to (1)
conﬁrm that TPP-induced toxicity in zebraﬁsh embryos is RAR-
dependent; (2) identify whether TPP-induced effects on cyp26a1
expression are localized to target organs such as the develop-
ing heart; and (3) identify RAR-dependent and RAR-independent
pathways that may be affected by TPP during embryogenesis.
Therefore, future studies should rely on RAR-speciﬁc morpholino
oligos, cyp26a1-speciﬁc whole-mount in situ hybridizations, and
whole genome expression proﬁling to better clarify the role
of RAR-relevant pathways in mediating developmental toxicity.
Nevertheless, our current ﬁndings continue to highlight the com-
plexity of deciphering mechanisms of developmental toxicity for
organophosphate-based ﬂame retardants such as TPP in zebraﬁsh
and other vertebrates.
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